Table 6.
Mitochondrial Function | Effect of PCOS on Mitochondrial Function | Method | Therapeutic Intervention | References |
---|---|---|---|---|
Biogenesis | Reduced “GG”(WT) frequency of PGC-1α rs8192678 polymorphism | PCR, RFLP Analysis | [90] | |
No difference in TFAM genotype or allele frequency | PCR, RFLP Analysis | [90] | ||
Mitochondrial Genome | Lower mtDNA copy number | qPCR | [92,93,94] | |
Higher mtDNA copy number | qPCR | [91] | ||
Negative association between mtDNA copy number and fasting insulin, HOMA-IR, waist circumference, and triglycerides | Pearson correlation coefficient | [94] | ||
Positive association between mtDNA copy number and quantitative insulin-sensitivity check index (QUICKI) and sex hormone-binding globulin (SHBG) | Pearson correlation coefficient | [94] | ||
No correlation between mtDNA copy number and anthropometric measure or 8-OHdG | qPCR, 8OH-dG ELISA kit | Metformin decreased mtDNA copy number at 6 and 12 months of treatment | [95] | |
Higher mtDNA4977 deletion rate | qPCR | [91] | ||
Higher frequency of a 9 bp deletion | qPCR | [49,96,97,98,99] | ||
ND5 gene polymorphisms: T12811C, T12338C | qPCR | [97,100,101] | ||
A6 gene polymorphisms: G8584A, C8684T | qPCR | [97,98,100] | ||
Unique tRNA variants and higher frequency of variants for Cys and Leu tRNAs | qPCR | [92,97,100] | ||
Greater frequency of D-loop SNPs C150T, T146C, A189G, and D310 | PCR, Mitomap, and mtDB mitochondria databases | [49,93] | ||
Carriers of AA genotype of PGC1a polymorphism rs8192678 and D-loop SNPs A189G and D310 had lower mtDNA | PCR, Mitomap, and mtDB mitochondria databases | [90,93] | ||
Ultrastructure | No Reports | |||
Metabolism | No Reports | |||
Dynamics | No Reports | |||
ROS and Repair | Decreased PRX3 2–3 h post-OGTT | ELISA | [103] | |
Positive correlation between PRX3 at 2 h post-OGTT and insulin at 1 h post-OGTT | Spearman correlation analysis | [103] |
PGC1: peroxisome proliferator-activated receptor gamma coactivator 1-alpha; TFAM: mitochondrial transcription factor A; HOMA-IR: Homeostatic Model Assessment for Insulin Resistance; PRX3: peroxiredoxin 3; OGTT: oral glucose tolerance test; RFLP: restriction fragment length polymorphism.